Allyson Rinderle (Menlo Park) joined KKR in 2017 and is a member of the Health Care industry team. She serves on the Board of Directors of Envision Healthcare and PetVet Care Centers and is a Board Observer of Impel NeuroPharma and Paige. Prior to joining KKR, Ms. Rinderle was a vice president at Longitude Capital, a health care venture growth firm. Previously, she was an analyst at Aisling Capital, a life science investment firm based in New York. Ms. Rinderle started her career as an analyst in J.P. Morgan’s health care investment banking practice where she was involved in a number of mergers, acquisitions, and financing transactions. Ms. Rinderle received her B.S. in Biomedical Engineering with distinction from Yale University, graduating magna cum laude, Tau Beta Pi, and Phi Beta Kappa. She holds an M.B.A. from Stanford Graduate School of Business, where she was an Arjay Miller Scholar and received a Certificate in Public Management and Social Innovation.